94447-0
HLA-DP and DQ and DR (class II) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
Active
Term Description
Laboratories that perform HLA antibody testing often report the specific antibodies found in categories based on the "amount" of each antibody found (called mean fluorescent intensity, MFI, for the common Luminex bead method). Theoretically, the antibodies present in higher concentrations, which are more likely to react with donor antigens, will have higher MFI values. Since risk stratification based on MFI range is not standardized and the exact cutoffs vary from lab to lab, this term is intended to report those HLA antibodies found in the higher risk stratification of MFI values (For one lab this was MFI > 5000, but some laboratories use 10,000 or another value).
Part Description
LP417656-8 HLA-DP & DQ & DR (class II) Ab.IgG high risk
The major histocompatibility complex (MHC) class I (A, B, and C) and II (DP, DM, DOA, DOB, DQ, and DR) in the human leukocyte antigen (HLA) system contains a large number of genes involved in immune system function in humans. The proteins encoded by some genes form antigens. HLA class I and II antigens are widely distributed on all nucleated cells and carried by platelets.
Antibodies specific to HLA class I and II antigens can be acquired through alloimmunization due to pregnancy, transfusion of blood products, or previous transplants. Alloimmunization can lead to production of antibodies in approximately one third of individuals. The presence of antibodies, specifically IgG, can affect the survival of transplant allografts or transfused platelets in sensitized individuals. Various testing methods are used to detect antibodies to HLA antigens.
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- HLA-DP & DQ & DR (class II) Ab.IgG high risk:
Prid: Pt: Ser/Plas: Nom: Flow cytometry - Long Common Name
- HLA-DP and DQ and DR (class II) IgG high risk [Identifier] in Serum or Plasma by Flow cytometry (FC)
- Short Name
- HLA class II Ab.IgG high risk SerPl FC
- Display Name
- HLA-DP & DQ & DR (class II) Ab.IgG high risk FC Nom
- Consumer Name Alpha Get Info
- HLA-DP & DQ & DR (class II) Ab.IgG high risk, Blood
Part Model Get Info
- Component
- HLA-DP & DQ & DR (class II) Ab.IgG high risk
LP417656-8
- Analyte
- HLA-DP & DQ & DR (class II) Ab.IgG high risk
LP417656-8
- Component Numerator
- HLA-DP & DQ & DR (class II) Ab.IgG high risk
LP417656-8
- Component Numerator Core
- HLA-DP & DQ & DR (class II) Ab.IgG high risk
LP417656-8
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Prid
LP6850-4
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Nom
LP7750-5
- Method
- Flow cytometry
LP6274-7
Example Answer List: LL3602-1
Source: NCBI PubMed| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Anti-DP1 | LA23895-8 | ||
| Anti-DP2 | LA23894-1 | ||
| Anti-DP3 | LA23897-4 | ||
| Anti-DP4 | LA23896-6 | ||
| Anti-DP5 | LA23898-2 | ||
| Anti-DP6 | LA23899-0 | ||
| Anti-DQ1 | LA23909-7 | ||
| Anti-DQ2 | LA23906-3 | ||
| Anti-DQ3 | LA23907-1 | ||
| Anti-DQ4 | LA23908-9 | ||
| Anti-DQ5(1) | LA23903-0 | ||
| Anti-DQ6(1) | LA23902-2 | ||
| Anti-DQ7(3) | LA23904-8 | ||
| Anti-DQ8(3) | LA23905-5 | ||
| Anti-DR1 | LA23910-5 | ||
| Anti-DR3 | LA23914-7 | ||
| Anti-DR4 | LA23915-4 | ||
| Anti-DR6 | LA23922-0 | ||
| Anti-DR7 | LA23916-2 | ||
| Anti-DR8 | LA23917-0 | ||
| Anti-DR10 | LA23918-8 | ||
| Anti-DR11(5) | LA23919-6 | ||
| Anti-DR12(5) | LA23920-4 | ||
| Anti-DR13(6) | LA23921-2 | ||
| Anti-DR14(6) | LA23923-8 | ||
| Anti-DR15(2) | LA23924-6 | ||
| Anti-DR16(2) | LA23925-3 | ||
| Anti-DR17(3) | LA23912-1 | ||
| Anti-DR18(3) | LA23913-9 | ||
| Anti-DR51 | LA23927-9 | ||
| Anti-DR52 | LA23926-1 | ||
| Anti-DR53 | LA23928-7 | ||
| Anti-DR103 | LA23911-3 |
Basic Attributes
- Class
- HLA
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.68 (ADD)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94428-0 | HLA class I and II IgG panel - Serum or Plasma by Flow cytometry (FC) |
| 94440-5 | HLA-DP and DQ and DR (class II) IgG panel - Serum or Plasma by Flow cytometry (FC) |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | HLA-DP a DQ a DR (třída II) IgG vysoké riziko: |
| el-GR | Greek (Greece) | Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP & DQ & DR (Κατηγορία IΙ) Αντισώματα IgG υψηλού κινδύνου: Synonyms: dP Nom Prid Pt Ανθρώπινα λευκοκυτταρικά αντιγόνα Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP Ανθρώπινα λευκοκυτταρικά αντιγόνα-DP & |
| es-ES | Spanish (Spain) | HLA-DP, DQ, DR (CLASE II) alto riesgo por Ac IgG: |
| es-MX | Spanish (Mexico) | HLA-DP & DQ & DR (clase II) Ab.IgG alto riesgo: |
| fr-FR | French (France) | HLA-DP et DQ et DR (classe II) anticorps IgG MFI forte: |
| it-IT | Italian (Italy) | HLA-DP & DQ & DR (classe II) Ab.IgG, rischio elevato: Synonyms: Citometria a flusso (FC) HLA tipizzazione tissutale antigeni-anticorpi HLA-DP e DQ e DR (classe II) Plasma Presenza o Identità Pressione differenziale Punto nel tempo (episodio) Rischio elevato di HLA-DP & |
| nl-NL | Dutch (Netherlands) | HLA-DP & DQ & DR (klasse II) As.IgG hoog risico: |
| pl-PL | Polish (Poland) | HLA-DP & DQ & DR (klasa II) Ab.IgG wysokiego ryzyka: Synonyms: HLA-DP i DQ i DR (klasa II) HLA-DP, DQ i DR IgG Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) Przeciwciała IgG do HLA-DP, DQ i DR (klasa II) wysokiego ryzyka wynik kategorialny |
| zh-CN | Chinese (China) | HLA-DP 与 DQ 与 DR (II 类) 抗体.IgG 高度风险: Synonyms: HLA II 类; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://